The classification of diabetes mellitus: A conceptual framework

Pediatric Clinics of North America

Volumn 52, Issue 6, 2005, Pages 1533-1552

  Ize Ludlow, Diego ^a   Sperling, Mark A ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; CALCIUM CHANNEL; EXENDIN 4; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOCORTICOID; GLUCOSE; INSULIN; LEPTIN;

CELL MEMBRANE DEPOLARIZATION; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG EFFECT; FOOD INTAKE; GENETIC RISK; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEARING IMPAIRMENT; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPOATROPHIC DIABETES MELLITUS; MATERNALLY INHERITED DIABETES AND DEAFNESS; MATURITY ONSET DIABETES MELLITUS; METABOLIC SYNDROME X; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; POTASSIUM TRANSPORT; PROTEIN DEGRADATION; PUBERTY; REVIEW; STOMACH EMPTYING;

BLOOD GLUCOSE; CHILD; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS;

EID: 27844511557     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2005.07.001     Document Type: Review

References (78)

1. R.N. Bergman, M. Ader, and K. Huecking Accurate assessment of beta-cell function: the hyperbolic correction Diabetes 51 Suppl 1 2002 S212 S220
2. J.C. Bruning, M.D. Michael, and J.N. Winnay A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance Mol Cell 2 1998 559 569
3. J.C. Bruning, J. Winnay, and S Bonner-Weir Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles Cell 88 1997 561 572
4. M.K. Badman, and J.S. Flier The gut and energy balance: visceral allies in the obesity wars Science 307 2005 1909 1914
5. D. Porte Jr, D.G. Baskin, and M.W. Schwartz Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans Diabetes 54 2005 1264 1276
6. M.W. Schwartz, and D. Porte Jr Diabetes, obesity, and the brain Science 307 2005 375 379
7. J. Rossi, P. Santamaki, and M.S. Airaksinen Parasympathetic innervation and function of endocrine pancreas requires the glial cell line-derived factor family receptor alpha2 (GFRalpha2) Diabetes 54 2005 1324 1330
8. D.M. Kemp, M.K. Thomas, and J.F. Habener Developmental aspects of the endocrine pancreas Rev Endocr Metab Disord 4 2003 5 17
9. S.A. Amiel, S. Caprio, and R.S. Sherwin Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism J Clin Endocrinol Metab 72 1991 277 282
10. T.A. Buchanan, and A.H. Xiang Gestational diabetes mellitus J Clin Invest 115 2005 485 491
11. M. Kojima, and K. Kangawa Ghrelin: structure and function Physiol Rev 85 2005 495 522
12. D.L. Williams, and D.E. Cummings Regulation of ghrelin in physiologic and pathophysiologic states J Nutr 135 2005 1320 1325
13. T. Vilsboll, and J.J. Holst Incretins, insulin secretion and type 2 diabetes mellitus Diabetologia 47 2004 357 366
14. J. Dupre Glycaemic effects of incretins in type 1 diabetes mellitus: a concise review, with emphasis on studies in humans Regul Pept 128 2005 149 157
15. J. Dupre, M.T. Behme, and T.J. McDonald Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes J Clin Endocrinol Metab 89 2004 3469 3473
16. T.A. Lutz Pancreatic amylin as a centrally acting satiating hormone Curr Drug Targets 6 2005 181 189
17. R.A. Heptulla, L.M. Rodriguez, and L. Bomgaars The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes Diabetes 54 2005 1100 1107
18. A. Caumo, and L. Luzi First-phase insulin secretion: does it exist in real life? Considerations on shape and function Am J Physiol Endocrinol Metab 287 2004 E371 E385
19. K.H. Gabbay The insulinopathies N Engl J Med 302 1980 165 167
20. M.A. Sperling Insulin biosynthesis and C-peptide: practical applications from basic research Am J Dis Child 134 1980 1119 1121
21. K. Hussain, and K.E. Cosgrove From congenital hyperinsulinism to diabetes mellitus: the role of pancreatic β-cell Katp channels Pediatr Diabetes 1 2005 1 11
22. J.R. Porter, and T.G. Barrett Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of pathology of insulin resistance and beta cell failure J Med Genet 2005 16
23. Diabetes Prevention Trial-Type 1 Diabetes Study Group Effects of insulin in relatives of patients with type 1 diabetes mellitus N Engl J Med 346 2002 1685 1691
24. G.I. Uwaifo, E.M. Fallon, and J. Chin Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children Diabetes Care 25 2002 2081 2087
25. N. Gungor, R. Saad, and J. Janosky Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents J Pediatr 144 2004 47 55
26. A.J. Scheen, M.J. Castillo, and P.J. Lefebvre Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications Diabetes Metab 22 1996 397 406
27. C. Greenbaum, K. Seidel, and C. Pihoker The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes Diabetes Care 27 2004 1202 1204
28. C.W. Yeckel, R. Weiss, and J. Dziura Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents J Clin Endocrinol Metab 89 2004 1096 1101
29. M. Keskin, S. Kurtoglu, and M. Kendirci Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents Pediatrics 115 2005 e500 e503
30. L.S. Conwell, S.G. Trost, and W.J. Brown Indexes of insulin resistance and secretion in obese children and adolescents: a validation study Diabetes Care 27 2004 314 319
31. W.S. Cutfield, R.N. Bergman, and R.K. Menon The modified minimal model: application to measurement of insulin sensitivity in children J Clin Endocrinol Metab 70 1990 1644 1650
32. R.N. Bergman, L.S. Phillips, and C. Cobelli Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose J Clin Invest 68 1981 1456 1467
33. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
34. J.C. Levy, D.R. Matthews, and M.P. Hermans Correct homeostasis model assessment (HOMA) evaluation uses the computer program Diabetes Care 21 1998 2191 2192
35. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modeling Diabetes Care 27 2004 1487 1495
36. A. Katz, S.S. Nambi, and K. Mather Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
37. G. Perseghin, A. Caumo, and M. Caloni Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals J Clin Endocrinol Metab 86 2001 4776 4781
38. T.M. Wallace, and D.R. Matthews The assessment of insulin resistance in man Diabet Med 19 2002 527 534
39. S. Soonthornpun, W. Setasuban, and A. Thamprasit Novel insulin sensitivity index derived from oral glucose tolerance test J Clin Endocrinol Metab 88 2003 1019 1023
40. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
41. F. Belfiore, S. Iannello, and G. Volpicelli Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels Mol Genet Metab 63 1998 134 141
42. J. Cederholm, and L. Wibell Insulin release and peripheral sensitivity at the oral glucose tolerance test Diabetes Res Clin Pract 10 1990 167 175
43. M. Gutt, C.L. Davis, and S.B. Spitzer Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures Diabetes Res Clin Pract 47 2000 177 184
44. M. Stumvoll, A. Mitrakou, and W. Pimenta Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity Diabetes Care 23 2000 295 301
45. A.T. Hattersley, R.C. Turner, and M.A. Permutt Linkage of type 2 diabetes to the glucokinase gene Lancet 339 1992 1307 1310
46. J.A. Maassen, L.M. 't Hart, and E. Van Essen Mitochondrial diabetes: molecular mechanisms and clinical presentation Diabetes 53 Suppl 1 2004 S103 S109
47. K. Ohkubo, A. Yamano, and M. Nagashima Mitochondrial gene mutations in the tRNA(Leu(UUR)) region and diabetes: prevalence and clinical phenotypes in Japan Clin Chem 47 2001 1641 1648
48. C.T. Moraes, E. Ricci, and E. Bonilla The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle Am J Hum Genet 50 1992 934 949
49. R.A. Hegele Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome Trends Endocrinol Metab 14 2003 371 377
50. E.A. Oral Lipoatrophic diabetes and other related syndromes Rev Endocr Metab Disord 4 2003 61 77
51. S.M. Grundy, H.B. Brewer Jr, and J.I. Cleeman Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Arterioscler Thromb Vasc Biol 24 2004 e13 e18
52. S. Ten, and N. Maclaren Insulin resistance syndrome in children J Clin Endocrinol Metab 89 2004 2526 2539
53. E. Diamanti-Kandarakis, C.R. Kouli, and A.T. Bergiele A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile J Clin Endocrinol Metab 84 1999 4006 4011
54. E.S. Knochenhauer, T.J. Key, and M. Kahsar-Miller Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study J Clin Endocrinol Metab 83 1998 3078 3082
55. M. Asuncion, R.M. Calvo, and J.L. San Millan A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain J Clin Endocrinol Metab 85 2000 2434 2438
56. A. Dunaif, K.R. Segal, and W. Futterweit Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174
57. D.A. Ehrmann, R.B. Barnes, and R.L. Rosenfield Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome Diabetes Care 22 1999 141 146
58. R.S. Legro, A.R. Kunselman, and W.C. Dodson Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 1999 165 169
59. American Diabetes Association Type 2 diabetes in children and adolescents Diabetes Care 23 2000 381 389
60. M. Landin-Olsson Latent autoimmune diabetes in adults Ann N Y Acad Sci 958 2002 112 116
61. C. Weyer, P.A. Tataranni, and C. Bogardus Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development Diabetes Care 24 2001 89 94
62. S. Lanng, A. Hansen, and B. Thorsteinsson Glucose tolerance in patients with cystic fibrosis: five year prospective study BMJ 311 1995 655 659
63. A.D. Mackie, S.J. Thornton, and F.P. Edenborough Cystic fibrosis-related diabetes Diabet Med 20 2003 425 436
64. R.W. Holl, A. Wolf, and A. Thon Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients J Pediatr Gastroenterol Nutr 25 1997 188 193
65. L. Dobson, C.D. Sheldon, and A.T. Hattersley Conventional measures underestimate glycaemia in cystic fibrosis patients Diabet Med 21 2004 691 696
66. B. Yung, F.H. Noormohamed, and M. Kemp Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction Diabet Med 19 2002 221 226
67. R.W. Holl, E. Heinze, and A. Wolf Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis Eur J Pediatr 154 1995 356 361
68. J. De Schepper, S. Hachimi-Idrissi, and J. Smitz First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters Horm Res 38 1992 260 263
69. C. Polychronakos Early onset diabetes mellitus: tip or iceberg? Pediatr Diabetes 5 2004 171 173
70. A. Austin, S.C. Kalhan, and D. Orenstein Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis J Clin Endocrinol Metab 79 1994 80 85
71. A. Moran, K.L. Pyzdrowski, and J. Weinreb Insulin sensitivity in cystic fibrosis Diabetes 43 1994 1020 1026
72. F. Lombardo, F. De Luca, and M. Rosano Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia Eur J Endocrinol 149 2003 53 59
73. D. Cucinotta, F. De Luca, and A. Gigante No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study Eur J Endocrinol 130 1994 253 258
74. S. Lanng, B. Thorsteinsson, and M.E. Roder Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance Clin Endocrinol (Oxf) 41 1994 217 223
75. D.S. Hardin, A. Leblanc, and G. Marshall Mechanisms of insulin resistance in cystic fibrosis Am J Physiol Endocrinol Metab 281 2001 E1022 E1028
76. D.S. Hardin, A. LeBlanc, and L. Para Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis Diabetes 48 1999 1082 1087
77. S. Tofe, J.C. Moreno, and L. Maiz Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis Eur J Endocrinol 152 2005 241 247
78. B. Ergun-Longmire, J. Marker, and A. Zeidler Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes Ann NY Acad Sci 1029 2004 260 277